Popular on Amzeal
- From Courtroom to Coinstore: Gram Trading Launches, Marking Lantah's Defiant Trademark Victory
- Generative AI University and Small Business Results Unite to Help Entrepreneurs Optimize Marketing and Growth
- Letters Of Hope ! Postal Apocalypse #LettersOfHope
- New Automated Platform Expands VSA's Omnichannel Capabilities
- Unmissable Lease-to-Own Opportunity: Luxury Home in Rotonda West with a Thriving Airbnb Business
- THINKWARE Announces Labor Day Dash Cam Specials
- Tobu Railway Is Operating the "Oze Night Train 23:45" On Select Dates in August, September, and October 2024!
- DialCare Announces New Chief Information Officer
- Studica Robotics Products Listed as FIRST® Legal for the FTC 2024 INTO THE DEEP Competition
- EVO Solar Inverters in Stock: Celebrate the 15th Anniversary with New Product Launch
Similar on Amzeal
- Energies Media: Unifying Insights Across the Energy Spectrum
- DocVilla Introduces Best All-in-One Customizable Cloud-Based EHR Practice Management Software for Multi-Specialty and Small Practices
- MGN Logistics, Inc. and Arvo A.I. Ltd Forge Game-Changing Partnership to Supercharge Freight Management!
- TalentWell Launches Next Generation of AI-powered Talent Sourcing with Automated, Personalized Videos
- Health is for EveryBODY™ Campaign Partners with Chip In™
- Introducing REA's Innovative Program: PathFinder Coaching™
- Planned Spin-Out to Focus on Gene Therapy for Type 1 and 2 Diabetes in Parallel to Treatments for Late Stage Lung Cancer: Genprex: Stock Symbol: GNPX
- Black Women Talk Tech's 'Roadmap to Billions' Conference Debuts in Toronto – Empowering Black Women in Tech
- An Officer and Gentlewoman, LLC Hired as Public Relations Partner for The Annual Atlanta Fashion and Polo Classic
- 5 Reasons to Choose a Local Sonoma County Photographer
Armata Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Amzeal News/10574830
LOS ANGELES, Sept. 5, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced that Deborah Birx, M.D., Chief Executive Officer, will participate in a corporate presentation at the H.C. Wainwright 26th Annual Global Investment Conference, which is being held in New York from September 9-11, 2024.
Armata's presentation is scheduled for Wednesday, September 11, from 8:00-8:30 AM ET.
About Armata Pharmaceuticals, Inc.
Armata is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. Armata is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. Armata is committed to advancing phage therapy with drug development expertise that spans bench to clinic including in-house phage specific cGMP manufacturing.
More on Amzeal News
Media Contacts:
At Armata:
Pierre Kyme
Armata Pharmaceuticals, Inc.
[email protected]
310-665-2928 x234
Investor Relations:
Joyce Allaire
LifeSci Advisors, LLC
[email protected]
212-915-2569
SOURCE Armata Pharmaceuticals, Inc.
Armata's presentation is scheduled for Wednesday, September 11, from 8:00-8:30 AM ET.
About Armata Pharmaceuticals, Inc.
Armata is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. Armata is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. Armata is committed to advancing phage therapy with drug development expertise that spans bench to clinic including in-house phage specific cGMP manufacturing.
More on Amzeal News
- Life with Lucia and Glynn: A Global Duo Spreading Joy Through Matching Shirts and Adventures
- Luxury Real Estate Agent James Edmunds lists luxury beach home in the heart of Deerfield Beach
- Sycamore Hills Dentistry Welcomes the Yomi Robot: The Future of Dental Implant Surgery
- MGN Logistics, Inc. and Arvo A.I. Ltd Forge Game-Changing Partnership to Supercharge Freight Management!
- HFES Launches Refreshed Website Design for Inclusive Collaboration and Engagement
Media Contacts:
At Armata:
Pierre Kyme
Armata Pharmaceuticals, Inc.
[email protected]
310-665-2928 x234
Investor Relations:
Joyce Allaire
LifeSci Advisors, LLC
[email protected]
212-915-2569
SOURCE Armata Pharmaceuticals, Inc.
Filed Under: Business
0 Comments
Latest on Amzeal News
- Govrn Unveils AI Assist to Address Board Data Challenges and Information Overload in the Boardroom
- L-Tron announces OSCR360 Tablet Software release v.2024.94.0
- OSCR360 featured at NYS Police FIU exhibit at the NY State Fair for Second Year
- Dr. Seth Chambers Shares Journey to Success in Implant Dentistry on Unofficial Podcast's Summer Series: "Mind, Body, & Arches"
- Datavalet is a Great Place to Work for the Second Year in a Row
- Health is for EveryBODY™ Campaign Partners with Chip In™
- Holiday Wine and Cider Tasting Event returns to the Hudson Valley
- Scott MacIntyre Graduates from Borrow Smart University Earns Certified Liability Advisor™ (CLA™) Designation
- Introducing REA's Innovative Program: PathFinder Coaching™
- Melanated Cares Foundation to Host 2024 Annual Camping Retreat "Melanated Campout" Powered by Winnebago Industries Foundation
- Health is for EveryBODY™ Welcomes Ciba Health as a Sponsor
- Are you a Life Sciences Startup in need of ADFFORDABLE WET LAB SPACE in BOSTON?
- The Future of Hiring Is Asynchronous According to Survey of 200 Jobseekers
- Planned Spin-Out to Focus on Gene Therapy for Type 1 and 2 Diabetes in Parallel to Treatments for Late Stage Lung Cancer: Genprex: Stock Symbol: GNPX
- I Feel Fine coming-of-age movie set for release on National Suicide Prevention Day
- BroadSource EMU Calling and Provisioning Protection (CAPP)
- SteepleMate Unveils AI-Powered Assist Tool to Revolutionize Church Management
- Women of Color STEM Conference Launches Inaugural Impact Awards
- VisualOn and Norlys Mark 10 Years of OTT Innovation, Reach Samsung Smart TV Integration Milestone
- Lineus Medical Announces a Reduction in Price for SafeBreak Vascular